Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalNo recent work listed

Xujun He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6979-2072; OpenAlex author ID A5100715896. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. First author DOI 10.1002/jcb.29533↗
  2. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance. Co-author DOI 10.3389/fonc.2020.617190↗
  3. REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9. Co-author DOI 10.1111/cas.12018↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hou‐Quan Tao · 2 shared papers, 2012–2021 · strength 0.22
  2. Rulin Sun · 1 shared paper, 2021 · strength 0.19
  3. Hongwei Sun · 1 shared paper, 2020 · strength 0.10
  4. Xianglai Ye · 1 shared paper, 2020 · strength 0.10
  5. Xiujuan Wei · 1 shared paper, 2020 · strength 0.10
  6. Jianxin Lyu · 1 shared paper, 2020 · strength 0.10
  7. Hezhi Fang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.